Combination treatment doubles survival for patients with advanced kidney cancer
A small clinical trial suggests that a duo of drugs can extend survival for people battling advanced kidney cancer.
Sep 17, 2024
0
39
Amino Acids, Peptides, and Proteins: News and Research on Bevacizumab
MeSH tree: D12.776.124.486.485.114.224.060.375
High-dose vitamin D3 does not provide benefit for metastatic colorectal cancer, clinical trial shows
SOLARIS (Alliance A021703), a multicenter, double-blind, randomized Phase III clinical trial led by Dana-Farber Cancer Institute researchers and conducted across several hundred cancer centers in the U.S. tested the addition ...
Sep 16, 2024
0
57
Gut bacteria influence responses to immunotherapy in mesothelioma patients, study finds
A cancer study has found that certain gut bacteria may influence whether or not a patient's immune system is successful in fighting mesothelioma, an aggressive form of cancer.
Sep 5, 2024
0
41
For treating retinopathy of prematurity, research proves that ranibizumab is safe
A University at Buffalo researcher who is a leading expert on retinopathy of prematurity (ROP) has published a study that could change the standard of care for the condition. ROP occurs in low birthweight premature babies; ...
May 13, 2024
0
47
Utilizing meta-analysis of tumor marker blood test kinetics in ovarian cancer patients
Patient prognosis and treatment response prediction are key factors in treating ovarian cancer, which is characterized by the lowest survival rate among gynecological cancers. Consequently, there is strong demand for a more ...
Apr 15, 2024
0
37
Cancer therapies show promise in combating tuberculosis
What could cancer teach us about tuberculosis? That's a question Meenal Datta has been chasing since she was a graduate student.
Mar 25, 2024
0
46
Research opens up a new approach for improving personalized treatment of patients with glioblastoma
A recent study opens up a novel approach for improving personalized treatments for patients with glioblastoma, one of the most aggressive types of cancer in existence today.
Jan 31, 2024
0
29
Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer
For patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) improves progression-free survival (PFS), ...
Jan 29, 2024
0
27
Toolkit for reducing cervical cancer risk
Cervical cancer is the fourth most common cancer in women globally, particularly in low- and middle-income countries. In the U.S., cervical cancer is no longer a common cause of cancer death because of the use of a screening ...
Jan 26, 2024
0
34
Experts address the latest advances in cervical cancer treatment
Although the incidence of cervical cancer has declined with increased screening and higher uptake of human papillomavirus (HPV) vaccination, cervical cancer remains the second highest cause of cancer mortality among women ...
Jan 25, 2024
0
58
